2021 Legislative and Public Policy Priorities This month, The NBCC Board of Directors met and approved a set of legislative […]
“Changes to FDA warnings and labeling should be grounded in rigorous, contemporary evidence—not post-hoc or subgroup re-analyses of older trials. ”
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
2021 Legislative and Public Policy Priorities This month, The NBCC Board of Directors met and approved a set of legislative […]
COVID-19 Vaccination and Cancer Are breast cancer patients considered high-risk and given priority for the COVID vaccines? It depends on […]
Early-stage hormone-receptor positive, HER2 negative (HR+/HER2-) breast cancer is the most commonly diagnosed type of breast cancer. While the majority […]
NBCC Champions Democracy All 50 states certified the ballots cast for President in the 2020 election. On January 6th as […]
The Honorable Nancy Pelosi U.S. House of Representatives Washington, DC 20515 I write on behalf of the National Breast Cancer […]
The National Breast Cancer Coalition’s advocates are deeply shocked by the shameful attack on our democracy on January 6. As […]
